Daniel Seifer, MD
Pulmonary Disease · Vancouver, WANPI 1407110356
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pulmonary disease clinicians in WA, where the typical reported total is $276.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 22 payments — averaging $17,203 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$250K
- Roche Products Limited$128K
How this compares
$0 in reported general payments places this provider in the 10th percentile of 275 pulmonary disease providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 19 | $215,682 |
| XolairOmalizumab | 36 | $171,595 |
| Pirfenidone | 11 | $50,511 |
| Dupixent PenDupilumab | 13 | $48,357 |
| NucalaMepolizumab | 12 | $41,614 |
| Breo ElliptaFluticasone/Vilanterol | 60 | $27,630 |
| Spiriva RespimatTiotropium Bromide | 29 | $15,424 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $11,099 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 33 | $8,390 |
| Advair HfaFluticasone Propion/Salmeterol | 16 | $5,560 |
| Mycophenolate Mofetil | 28 | $5,151 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $2,846 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $511 |
| Azithromycin | 30 | $405 |
| Azathioprine | 13 | $342 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Vancouver
- Nicholas WyshamVancouver$117K
- Todd GienappVancouver$6K
- Bhanu PatibandlaVancouver$4K
- Jed GordenSeattle$236K
- Dominique PepperOlympia$212K
- Jiten PatelSpokane$200K
- Oneil BainsSeattle$156K
- Ganesh RaghuSeattle$147K
- Colleen OverdorfBellingham$110K
- Jeffrey CarySeattle$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.